Author

Martín Emilio Lázaro Quintela

Observed names: M. E. Lázaro Quintela, Martin Emilio Lazaro Quintela, Martín Lázaro-Quintela

Institutions: University Hospital Complex Of Vigo, Servicio Gallego de Salud, Complejo Hospitalario de Pontevedra, Universidade de Vigo

Observed institutions: University Hospital Complex Of Vigo, Servicio Gallego de Salud, Complejo Hospitalario de Pontevedra, Universidade de Vigo

OpenAlex ID: A5023835682

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

2020 · Yi-Long Wu, Ying Cheng, et al. · The Lancet Respiratory Medicine · 260

Renal primary angiosarcoma

2007 · B. Carnero López, I. Fernández Pérez, et al. · Clinical & Translational Oncology · 15

Randomized phase II study of docetaxel (D) + abiraterone acetate (AA) versus D after disease progression to first-line AA in metastatic castration-resistant prostate cancer (mCRPC): ABIDO-SOGUG Trial.

2020 · Miguel Angel Climent Duran, Albert Font, et al. · Journal of Clinical Oncology · 2

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.

2019 · Noemi De Dios Alvarez, Marinha Costa Rivas, et al. · Journal of Clinical Oncology · 1

Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study)

2026 · Ignacio Peláez Fernández, Verónica Blanco Lorenzo, et al. · Clinical & Translational Oncology

Baseline intratumoral TCRβ and TCRγ repertoires predict response to immune checkpoint inhibitors in advanced renal cell carcinoma

2026 · Manuel Pino-González, Martín Lázaro-Quintela, et al. · medRxiv

Clinical outcomes and survival in patients with NSCLC and EGFR exon 20 mutations: evidence from real-world clinical practice in a retrospective study in Galicia

2026 · Begoña Campos Balea, Martín Emilio Lázaro Quintela, et al. · Frontiers in Oncology

ECO Experts’ consensus on establishing renal cancer healthcare quality measures in Spain.

2020 · Vicente Guillem, Javier Puente, et al. · Journal of Clinical Oncology

Expert consensus on the development of quality care measures for kidney cancer in Spain.

2020 · Vicente Guillem, Carlos Camps, et al. · Journal of Clinical Oncology

Works count: 9

Citation count: 278

H-index: 2

I10-index: 2